What is Sequencing.com?
Sequencing.com specializes in genetic testing and whole genome sequencing, providing individuals with comprehensive DNA reports for personalized health and wellness insights. The platform offers assessments for over 15,000 diseases and conditions, with the unique capability for continuous reanalysis of genetic data against the latest scientific research. This positions the company as a key player for individuals seeking deeper understanding of their health, including family planning and rare disease diagnosis. A core tenet of their operation is data privacy, with a firm commitment to never selling customer information and maintaining stringent data protection standards.
How much funding has Sequencing.com raised?
Sequencing.com has raised a total of $5M across 1 funding round:
Other Financing Round
$5M
Other Financing Round (2022): $5M with participation from Lerer Hippeau Ventures, Red Antler, Red Sea Ventures, and XRC Labs
Key Investors in Sequencing.com
Lerer Hippeau Ventures
Lerer Hippeau is a venture capital firm focused on investing in innovative startups, particularly in the early stages such as Seed and Pre-Seed rounds. They aim to support founders with great ideas who are willing to tackle challenging problems, fostering long-term success through their expertise as former operators. The firm invests across both enterprise and consumer landscapes, embodying a community spirit reminiscent of New York's audacity and resilience. Their portfolio reflects a commitment to redefining and creating new industry categories.
Red Antler
Founded in 2007 and headquartered in Brooklyn, New York, Red Antler is a marketing and advertising company that specializes in branding and launching new businesses. Their services include research, brand strategy, naming, brand identity, digital design, engineering, industrial design, marketing & activation, and content production.
Red Sea Ventures
Red Sea Ventures is a New York City-based venture capital fund that invests in early-stage technology-enabled companies aimed at transforming industries and enhancing consumer experiences. The firm focuses on startups in sectors such as next-generation commerce, the future of work, and consumer health. With a portfolio that includes notable companies like Allbirds and Sweetgreen, Red Sea Ventures targets innovative businesses that are reshaping consumer and enterprise landscapes. The team, led by experienced entrepreneurs and investors, is actively involved in the startup community, providing mentorship and support to emerging companies.
What's next for Sequencing.com?
The substantial enterprise-level funding and recent strategic investment signal a period of accelerated growth and market expansion for Sequencing.com. This capital infusion is likely to fuel advancements in their sequencing technology, enhance their analytical capabilities, and broaden their reach within the health-tech and personalized medicine sectors. The company is poised to further solidify its position by leveraging this financial momentum to drive innovation and potentially explore new avenues for genetic data application, reinforcing its commitment to empowering individuals with actionable genetic insights.
See full Sequencing.com company page
